Ruyi Shi

1.5k total citations
19 papers, 256 citations indexed

About

Ruyi Shi is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ruyi Shi has authored 19 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Ruyi Shi's work include Cellular Mechanics and Interactions (5 papers), Melanoma and MAPK Pathways (3 papers) and RNA Interference and Gene Delivery (2 papers). Ruyi Shi is often cited by papers focused on Cellular Mechanics and Interactions (5 papers), Melanoma and MAPK Pathways (3 papers) and RNA Interference and Gene Delivery (2 papers). Ruyi Shi collaborates with scholars based in China and United States. Ruyi Shi's co-authors include Chao Fu, Pengzhou Kong, Bin Song, Yanghui Bi, Yang Liu, Miao Wang, Xiaolong Cheng, Caixia Cheng, Hongqin Wang and Xiaodong Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Molecular Cancer.

In The Last Decade

Ruyi Shi

19 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruyi Shi China 10 160 76 47 39 31 19 256
Rita Carvalho Portugal 7 236 1.5× 122 1.6× 52 1.1× 17 0.4× 43 1.4× 10 317
Khalid N. Al‐Zahrani Canada 10 147 0.9× 34 0.4× 52 1.1× 67 1.7× 12 0.4× 17 238
Chaojie Wang United States 9 192 1.2× 46 0.6× 64 1.4× 31 0.8× 51 1.6× 14 325
Azusa Yamato Japan 8 207 1.3× 64 0.8× 73 1.6× 42 1.1× 20 0.6× 12 313
Haruko Kunitomi Japan 9 183 1.1× 112 1.5× 71 1.5× 24 0.6× 31 1.0× 17 311
Zheshen Jiang Belgium 9 213 1.3× 64 0.8× 71 1.5× 34 0.9× 15 0.5× 11 300
Jintong Ji China 10 192 1.2× 100 1.3× 81 1.7× 18 0.5× 35 1.1× 12 303
Mattia Buratto Italy 11 124 0.8× 53 0.7× 103 2.2× 14 0.4× 112 3.6× 21 491
Oddveig Rikardsen Norway 9 135 0.8× 65 0.9× 138 2.9× 30 0.8× 34 1.1× 17 373
Janson W.T. Tse Australia 6 199 1.2× 78 1.0× 64 1.4× 14 0.4× 20 0.6× 8 260

Countries citing papers authored by Ruyi Shi

Since Specialization
Citations

This map shows the geographic impact of Ruyi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyi Shi more than expected).

Fields of papers citing papers by Ruyi Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruyi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyi Shi. The network helps show where Ruyi Shi may publish in the future.

Co-authorship network of co-authors of Ruyi Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ruyi Shi. A scholar is included among the top collaborators of Ruyi Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruyi Shi. Ruyi Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Jiaqi, Qian Chen, Li Li, et al.. (2025). Sestrin 2 mediates OA chondrocyte cluster formation via reduced PCM stiffness using in situ softened alginate-collagen hydrogel. Materials Today Communications. 47. 112974–112974. 1 indexed citations
2.
Shi, Ruyi, Xingcong Ren, Hongyan Jia, et al.. (2024). NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer. Molecular Cancer. 23(1). 188–188. 3 indexed citations
3.
Zhang, Jiaqi, et al.. (2024). Development of alginate-collagen interpenetrating network for osteoarthritic cartilage by in situ softening. International Journal of Biological Macromolecules. 266(Pt 2). 131259–131259. 8 indexed citations
4.
Meng, Debin, Ruyi Shi, Feng Li, et al.. (2024). LncRNA WFDC21P interacts with SEC63 to promote gastric cancer malignant behaviors by regulating calcium homeostasis signaling pathway. Cancer Cell International. 24(1). 111–111. 1 indexed citations
5.
Yang, Bin, Huijuan Liu, Yanghui Bi, et al.. (2020). MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma. International Journal of Medical Sciences. 17(13). 2013–2023. 27 indexed citations
6.
Kang, Jing, Juanjuan Wang, Jihua Tian, et al.. (2020). The emerging role of EGFL6 in angiogenesis and tumor progression. International Journal of Medical Sciences. 17(10). 1320–1326. 17 indexed citations
7.
Fu, Chao & Ruyi Shi. (2020). Osteoclast biology in bone resorption: a review. SHILAP Revista de lepidopterología. 1(4). e57–e57. 31 indexed citations
8.
Zhang, Yanyan, Ruyi Shi, Yike Li, et al.. (2019). Mps1 is associated with the BRAFV600E mutation and predicts poor outcome in patients with colorectal cancer. Oncology Letters. 17(3). 2809–2817. 3 indexed citations
9.
Bai, Yinshan, Cui Zhu, Hengxi Wei, et al.. (2018). Previously claimed male germline stem cells from porcine testis are actually progenitor Leydig cells. Stem Cell Research & Therapy. 9(1). 200–200. 4 indexed citations
10.
Hu, Xiao, Yuanfang Zhai, Ruyi Shi, et al.. (2018). FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma. Oncology Reports. 39(5). 2136–2146. 23 indexed citations
11.
Hu, Xiao, Yuanfang Zhai, Guodong Li, et al.. (2018). [FAT1 inhibits cell proliferation of esophageal squamous cell carcinoma through regulating the expression of CDK4/CDK6/CCND1 complex].. PubMed. 40(1). 14–20. 3 indexed citations
12.
Li, Yike, Pengzhou Kong, Caixia Cheng, et al.. (2018). Mps1 is associated with the BRAFV600E mutation but does not rely on the classic RAS/RAF/MEK/ERK signaling pathway in thyroid carcinoma. Oncology Letters. 15(6). 9978–9986. 4 indexed citations
14.
Shi, Ruyi, Xun Huang, Xiao Hu, et al.. (2016). Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties. Oncology Reports. 36(2). 984–990. 26 indexed citations
15.
Kong, Pengzhou, et al.. (2016). Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer. Oncotarget. 7(34). 55601–55610. 18 indexed citations
16.
Shi, Ruyi, Heyang Cui, Yanghui Bi, et al.. (2015). Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma. Oncology Letters. 9(5). 2249–2255. 20 indexed citations
17.
Shi, Ruyi, et al.. (2013). Anti-miRNA-23a Oligonucleotide Suppresses Glioma Cells Growth by Targeting Apoptotic Protease Activating Factor-1. Current Pharmaceutical Design. 19(35). 6382–6389. 37 indexed citations
18.
Zhang, Ling, Ruyi Shi, Caixia Cheng, et al.. (2013). Oncogenic B-RafV600E abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells. Cancer Letters. 337(1). 125–132. 14 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026